Arthur Fratamico
Directeur/Membre du Conseil chez PANBELA THERAPEUTICS, INC.
Fortune : - $ au 30/06/2024
Postes actifs de Arthur Fratamico
Sociétés | Poste | Début | Fin |
---|---|---|---|
PANBELA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 16/12/2019 | - |
Independent Dir/Board Member | 16/12/2019 | - | |
Radiant Biotherapeutics, Inc.
Radiant Biotherapeutics, Inc. BiotechnologyHealth Technology Radiant Biotherapeutics, Inc. develops multi-valent and specific bio therapeutics solutions. Arthur J. Fratamico has been the CEO of the Canadian company since 2021. | Directeur Général | 01/05/2021 | - |
President | 01/05/2021 | - |
Historique de carrière de Arthur Fratamico
Anciens postes connus de Arthur Fratamico
Sociétés | Poste | Début | Fin |
---|---|---|---|
VITAE PHARMACEUTICALS INC | Corporate Officer/Principal | 08/07/2014 | 25/12/2016 |
FLEXION THERAPEUTICS, INC. | Corporate Officer/Principal | 19/06/2012 | 01/01/2014 |
GALERA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2017 | - |
TREVENA, INC. | Corporate Officer/Principal | 12/04/2011 | - |
Hoechst Marion Roussel, Inc. | Corporate Officer/Principal | - | - |
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Corporate Officer/Principal | - | - |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Corporate Officer/Principal | 17/09/2009 | - |
Formation de Arthur Fratamico
Drexel University | Masters Business Admin |
Philadelphia College of Pharmacy | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 11 |
Canada | 2 |
Opérationnelle
Corporate Officer/Principal | 7 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 9 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
TREVENA, INC. | Health Technology |
GALERA THERAPEUTICS, INC. | Health Technology |
PANBELA THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Health Technology |
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
Hoechst Marion Roussel, Inc. | |
Flexion Therapeutics, Inc.
Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
Vitae Pharmaceuticals LLC
Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
Radiant Biotherapeutics, Inc.
Radiant Biotherapeutics, Inc. BiotechnologyHealth Technology Radiant Biotherapeutics, Inc. develops multi-valent and specific bio therapeutics solutions. Arthur J. Fratamico has been the CEO of the Canadian company since 2021. | Health Technology |
- Bourse
- Insiders
- Arthur Fratamico
- Expérience